JENNISON ASSOCIATES LLC – Apellis Pharmaceuticals, Inc. Transaction History
JENNISON ASSOCIATES LLC portfolio value:
$173.12M
portfolio value
JENNISON ASSOCIATES LLC quarter portfolio value change:
+51.04%
quarter
Apellis Pharmaceuticals, Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Increase | +10.28% | 236.36K shares | 69.19M | $68.3 | 2.53M |
Q2 2022 | share | Decrease | -15.01% | -406.04K shares | -33.47M | $45.22 | 2.29M |
Q1 2022 | share | Increase | +45.23% | 842.23K shares | 49.36M | $50.81 | 2.70M |
Q4 2021 | share | Decrease | -10.42% | -216.68K shares | 19.52M | $47.95 | 1.86M |
Q3 2021 | share | Decrease | -15.13% | -370.67K shares | -86.29M | $32.96 | 2.07M |
Q2 2021 | share | Decrease | -9.64% | -261.35K shares | 38.48M | $63.2 | 2.44M |
Q1 2021 | share | Decrease | -2.22% | -61.54K shares | -42.25M | $42.91 | 2.71M |
Q4 2020 | share | Decrease | -2.30% | -65.36K shares | 72.96M | $57.2 | 2.77M |
Q3 2020 | share | Increase | +33.41% | 710.70K shares | 16.14M | $30.17 | 2.83M |
Q2 2020 | share | Increase | +1.80% | 37.56K shares | 13.49M | $32.66 | 2.12M |
Q1 2020 | share | Increase | +89.09% | 984.48K shares | 22.14M | $26.79 | 2.08M |
Q4 2019 | share | Increase | +0.61% | 6.67K shares | 7.37M | $30.62 | 1.10M |
Q3 2019 | share | Increase | +18.97% | 175.11K shares | 3.06M | $24.09 | 1.09M |
Q2 2019 | share | Increase | +57.18% | 335.86K shares | 11.94M | $25.34 | 923.24K |
Q1 2019 | share | Increase | +0.08% | 457 shares | 3.71M | $19.5 | 587.38K |
Q4 2018 | share | Increase | +2.10% | 12.06K shares | -2.47M | $13.19 | 586.92K |
Q3 2018 | share | Increase | +0.77% | 4.39K shares | -2.32M | $17.78 | 574.85K |
Q2 2018 | share | Increase | +50.46% | 191.31K shares | 4.16M | $22 | 570.46K |
Q1 2018 | share | Decrease | -37.53% | -227.77K shares | -4.78M | $22.11 | 379.15K |
Q4 2017 | share | Increase | 0.00% | 606.92K shares | 13.17M | $21.7 | 606.92K |